CUBE vs MAZE · P/E 25, rev $1.07B vs $525.3M cap
CubeSmart (CUBE) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the CUBE and MAZE stock pages for the full models.
Not investment advice.